Drug intelligence / Profile preview

Hibiscus sabdariffa + Centella asiatica

Development stage
Unknown
Lead developer
Casa Espírita Terra de Ismael
Administration
Oral
01

Overview

Hibiscus sabdariffa + Centella asiatica is an investigational composite herbal medicine being developed by Casa Espirita Terra de Ismael in collaboration with the University of Sao Paulo for the treatment of iron deficiency anemia. The therapy consists of a combination of powdered dry Hibiscus sabdariffa (200 mg) and a tincture of Centella asiatica (40 drops), administered twice daily. It is currently being evaluated in a Phase 3 clinical trial to compare its efficacy in increasing hemoglobin levels against standard iron sulphate treatment. The study also aims to determine how genetic polymorphisms in iron-related enzymes and transporters, specifically Divalent Metal Transporter 1 (DMT1) and Ferroportin, influence the therapeutic response to this herbal intervention.

Other names
Hibiscus sabdariffa plus Centella asiatica composite herbal medicineherbal medicine-Casa Espirita Terra de Ismael-iron deficiency anemia

Beyond the preview

Go deeper on Hibiscus sabdariffa + Centella asiatica.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hibiscus sabdariffa + Centella asiatica.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call